Related Experiment Video
Updated: Feb 9, 2026

Author Spotlight: Enhancing CAR-T Cell Function in Syngeneic Tumor Models
Published on: February 2, 2024
CAR-modified marrow infiltrating lymphocytes efficiently target malignant plasma cells with very low antigen density
Nicolas Camviel1, Davide Gambarotto2, Violaine Andre1
1Department of Oncology UNIL-CHUV, University Hospital Lausanne (CHUV) and University of Lausanne (UNIL), 1011 Lausanne, Switzerland; Ludwig Institute for Cancer Research Lausanne, 1011 Lausanne, Switzerland; Swiss Cancer Center Léman, 1011 Lausanne, Switzerland; AGORA Cancer Research Center, 1011 Lausanne, Switzerland.
Abstract:
B cell maturation antigen (BCMA) is the primary target for chimeric antigen receptor (CAR)-T cell therapies and other immunotherapies in multiple myeloma (MM). Frequent relapses and the need for sequential treatments underscore the importance of alternative targets. We previously developed a dual-antigen-specific CAR recognizing both BCMA and transmembrane activator and CAML interactor (TACI). Here, we efficiently expressed this CAR in patient-derived marrow-infiltrating lymphocytes (MILs) to investigate MM cell killing via both endogenous T cell receptor (TCR) specificities and the CAR. While the patients' MIL TCRs did not recognize or kill autologous malignant plasma cells (PCs), the CAR consistently mediated efficient PC killing even at low or undetectable antigen levels by flow cytometry. Quantification of BCMA and TACI molecules on target cells by direct stochastic optical reconstruction microscopy (dSTORM) revealed that both BCMA and TACI were significantly underestimated by flow cytometry. Analysis by dSTORM allowed us to delineate the dual-antigen sensitivity of the CAR, indicating that CAR-MILs were polyfunctional and killed targets at very low antigen densities. Our findings support the further exploration of TACI as target in MM and underline the value of super-resolution microscopy in assessing antigen density thresholds for CAR-T cells.
Insights
Chimeric antigen receptor (CAR) T cells targeting BCMA and TACI show promise for multiple myeloma (MM). Dual-targeting CAR T cells effectively kill cancer cells, even with low antigen levels, suggesting TACI as a viable target.
Area of Science:
- Immunology
- Oncology
- Biotechnology
Background:
- B cell maturation antigen (BCMA) is a key target for multiple myeloma (MM) immunotherapies.
- Frequent relapses necessitate alternative therapeutic targets beyond BCMA.
Purpose of the Study:
- To investigate the efficacy of a dual-specific chimeric antigen receptor (CAR) T cell therapy targeting both BCMA and Transmembrane activator and CAML interactor (TACI) in MM.
- To evaluate the killing of MM cells by CAR T cells derived from patient marrow infiltrating lymphocytes (MILs).
Main Methods:
- Development of a dual-specific CAR recognizing BCMA and TACI.
- Expression of the CAR in patient-derived MILs.
- Assessment of MM cell killing using flow cytometry and direct stochastic optical reconstruction microscopy (dSTORM).
Main Results:
- CAR T cells efficiently killed malignant plasma cells (PCs) despite low or undetectable antigen levels by flow cytometry.
- dSTORM revealed significantly underestimated BCMA and TACI expression levels compared to flow cytometry.
- CAR T cells demonstrated polyfunctional killing capabilities at very low antigen densities.
Conclusions:
- Transmembrane activator and CAML interactor (TACI) is a promising target for MM treatment.
- Super-resolution microscopy (dSTORM) is valuable for assessing antigen density thresholds for CAR T cell therapies.
- Dual-targeting CAR T cells offer a potent strategy against multiple myeloma.
Related Concept Videos
Antigen Presenting Cells
T cells require the help of antigen-presenting cells (APCs), which process foreign antigens into smaller fragments that can be recognized by T cells. These APCs are highly specialized cells that efficiently internalize antigens...
Protein Buffers in Blood Plasma and Cells
Certain amino acids can exist in a zwitterion state at a...
Density
Current Density
Target Cell Response to Hormones
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Strain-Energy Density
In the elastic region of a material, the relationship between the stress and the strain is linear and follows Hooke's Law. The strain energy density in this region...

